SCHEMBL6167327

SCHEMBL6167327

CC(C)(C)c1nn(-c2ccccn2)c2c1C(=O)CCC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
THRB P10828 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
KDM4E B2RXH2 5/20 0.42
HPGD P15428 4/20 0.42
GAA P10253 2/20 0.42
CCNA2 P20248 8/20 0.41
CDK2 P24941 8/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
TP53 P04637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CCNO P22674 1/20 0.41
CCNE1 P24864 1/20 0.41
CCNA1 P78396 1/20 0.41
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167242 0.84 ALDH1A1 (0.62) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6167303 0.82 ALDH1A1 (0.45) ALDH1A1MAPTSMN1; SMN2KDM4EHPGD
SCHEMBL6164595 0.81 CCNA2 (0.47) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6164726 0.81 CCNA2 (0.47) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6164472 0.80 ALDH1A1 (0.48) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6165207 0.80 ALDH1A1 (0.46) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6164396 0.79 ALDH1A1 (0.41) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6165407 0.78 ALDH1A1 (0.46) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6164779 0.78 SMN1; SMN2 (0.44) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6163605 0.78 ALDH1A1 (0.51) ALDH1A1MAPTSMN1; SMN2THRBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed